CPHA Canvax
  • Availability, rollout and prioritization in Ontario
  • Emerging evidence: specific populations, adverse events and vaccine dosage interval
  • Ensuring patient confidence in vaccines
  • Types of COVID-19 vaccines
  • Pfizer-BioNTech mRNA vaccine
  • Moderna mRNA vaccine
  • Patient resources
  • Top resources
Rating See Comments Ratings


Program Planning and Delivery,Professional Development,Education and Training,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and Delivery
Professional Development
Education and Training
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.